Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model W Arap, R Pasqualini, E Ruoslahti Science 279 (5349), 377-380, 1998 | 2868 | 1998 |
Organ targeting In vivo using phage display peptide libraries R Pasqualini, E Ruoslahti Nature 380 (6572), 364-366, 1996 | 1678 | 1996 |
Anti-cancer activity of targeted pro-apoptotic peptides HM Ellerby, W Arap, LM Ellerby, R Kain, R Andrusiak, GD Rio, ... Nature medicine 5 (9), 1032-1038, 1999 | 1182 | 1999 |
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis R Pasqualini, E Koivunen, R Kain, J Lahdenranta, M Sakamoto, A Stryhn, ... Cancer research 60 (3), 722-727, 2000 | 1167 | 2000 |
αv integrins as receptors for tumor targeting by circulating ligands R Pasqualini, E Koivunen, E Ruoslahti Nature biotechnology 15 (6), 542-546, 1997 | 1029 | 1997 |
A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial … DO Traktuev, S Merfeld-Clauss, J Li, M Kolonin, W Arap, R Pasqualini, ... Circulation research 102 (1), 77-85, 2008 | 1028 | 2008 |
Steps toward mapping the human vasculature by phage display W Arap, MG Kolonin, M Trepel, J Lahdenranta, M Cardó-Vila, ... Nature medicine 8 (2), 121-127, 2002 | 767 | 2002 |
Reversal of obesity by targeted ablation of adipose tissue MG Kolonin, PK Saha, L Chan, R Pasqualini, W Arap Nature medicine 10 (6), 625-632, 2004 | 756 | 2004 |
Tumor targeting with a selective gelatinase inhibitor E Koivunen, W Arap, H Valtanen, A Rainisalo, OP Medina, P Heikkilä, ... Nature biotechnology 17 (8), 768-774, 1999 | 735 | 1999 |
Three-dimensional tissue culture based on magnetic cell levitation GR Souza, JR Molina, RM Raphael, MG Ozawa, DJ Stark, CS Levin, ... Nature nanotechnology 5 (4), 291-296, 2010 | 732 | 2010 |
Intravascular delivery of particulate systems: does geometry really matter? P Decuzzi, R Pasqualini, W Arap, M Ferrari Pharmaceutical research 26, 235-243, 2009 | 731 | 2009 |
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. D Rajotte, W Arap, M Hagedorn, E Koivunen, R Pasqualini, E Ruoslahti The Journal of clinical investigation 102 (2), 430-437, 1998 | 698 | 1998 |
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors OJ Müller, F Kaul, MD Weitzman, R Pasqualini, W Arap, JA Kleinschmidt, ... Nature biotechnology 21 (9), 1040-1046, 2003 | 533 | 2003 |
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands MA Arap, J Lahdenranta, PJ Mintz, A Hajitou, ÁS Sarkis, W Arap, ... Cancer cell 6 (3), 275-284, 2004 | 501 | 2004 |
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization K Ogawa, R Pasqualini, RA Lindberg, R Kain, AL Freeman, EB Pasquale Oncogene 19 (52), 6043-6052, 2000 | 494 | 2000 |
Fingerprinting the circulating repertoire of antibodies from cancer patients PJ Mintz, J Kim, KA Do, X Wang, RG Zinner, M Cristofanilli, MA Arap, ... Nature biotechnology 21 (1), 57-63, 2003 | 439 | 2003 |
Targeting the prostate for destruction through a vascular address W Arap, W Haedicke, M Bernasconi, R Kain, D Rajotte, S Krajewski, ... Proceedings of the National Academy of Sciences 99 (3), 1527-1531, 2002 | 439 | 2002 |
Genetic basis for in vivo daptomycin resistance in enterococci CA Arias, D Panesso, DM McGrath, X Qin, MF Mojica, C Miller, L Diaz, ... New England Journal of Medicine 365 (10), 892-900, 2011 | 434 | 2011 |
Display technologies: application for the discovery of drug and gene delivery agents A Sergeeva, MG Kolonin, JJ Molldrem, R Pasqualini, W Arap Advanced drug delivery reviews 58 (15), 1622-1654, 2006 | 415 | 2006 |
CD13/APN is activated by angiogenic signals and is essential for capillary tube formation SV Bhagwat, J Lahdenranta, R Giordano, W Arap, R Pasqualini, ... Blood, The Journal of the American Society of Hematology 97 (3), 652-659, 2001 | 392 | 2001 |